{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:23:31Z","timestamp":1788895411685,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010676","name":"Horizon 2020 Societal Challenges","doi-asserted-by":"publisher","award":["964997"],"award-info":[{"award-number":["964997"]}],"id":[{"id":"10.13039\/100010676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["847912"],"award-info":[{"award-number":["847912"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["VEGA 1\/0434\/24"],"award-info":[{"award-number":["VEGA 1\/0434\/24"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["ANR-19-SYME-0001\\u201305"],"award-info":[{"award-number":["ANR-19-SYME-0001\\u201305"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["VEGA 2\/0067\/22"],"award-info":[{"award-number":["VEGA 2\/0067\/22"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 grantov\u00e1 agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["VEGA 1\/0434\/24"],"award-info":[{"award-number":["VEGA 1\/0434\/24"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 grantov\u00e1 agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["VEGA 2\/0067\/22"],"award-info":[{"award-number":["VEGA 2\/0067\/22"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.drup.2026.101350","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:09:12Z","timestamp":1767370152000},"page":"101350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance"],"prefix":"10.1016","volume":"85","author":[{"given":"Lenka","family":"Trnkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4697-6389","authenticated-orcid":false,"given":"Monika","family":"Burikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Soltysova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Ficek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9356-6219","authenticated-orcid":false,"given":"Jana","family":"Plava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cumova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Rojikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Jakic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Sedlackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Tichy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojtech","family":"Bystry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1459-7712","authenticated-orcid":false,"given":"Florence","family":"Busato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4327-3932","authenticated-orcid":false,"given":"Yimin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0747-9275","authenticated-orcid":false,"given":"Miroslava","family":"Matuskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-6659","authenticated-orcid":false,"given":"Lucia","family":"Kucerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir Frode","family":"\u00d8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4797-1600","authenticated-orcid":false,"given":"Gunhild Mari","family":"M\u00e6landsmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0985-8460","authenticated-orcid":false,"given":"Thomas","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2683-0817","authenticated-orcid":false,"given":"Jorg","family":"Tost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0692-1858","authenticated-orcid":false,"given":"Svetlana","family":"Miklikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cihova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2466-9126","authenticated-orcid":false,"given":"Verona","family":"Buocikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-5652","authenticated-orcid":false,"given":"Bozena","family":"Smolkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101350_bib1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41594-023-01181-7","article-title":"The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer","volume":"31","author":"Achinger-Kawecka","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.drup.2026.101350_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.molonc.2009.07.003","article-title":"Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models","volume":"3","author":"Bergamaschi","year":"2009","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.drup.2026.101350_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2026.101350_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112662","article-title":"Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models","volume":"147","author":"Buocikova","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.drup.2026.101350_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.991751","article-title":"Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression","volume":"13","author":"Buocikova","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.drup.2026.101350_bib6","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1073\/pnas.0803513105","article-title":"Topoisomerase levels determine chemotherapy response in vitro and in vivo","volume":"105","author":"Burgess","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101350_bib7","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1158\/0008-5472.CAN-10-0545","article-title":"FoxM1 mediates resistance to herceptin and paclitaxel","volume":"70","author":"Carr","year":"2010","journal-title":"Cancer Res"},{"issue":"36","key":"10.1016\/j.drup.2026.101350_bib8","first-page":"0","article-title":"rCGH: Comprehensive Pipeline for Analyzing and Visualizing Array-Based CGH Data","volume":"1","author":"Commo","year":"2024","journal-title":"R. Package Version"},{"key":"10.1016\/j.drup.2026.101350_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/hep.15.41","article-title":"Mechanisms of doxorubicin resistance in hepatocellular carcinoma","volume":"3","author":"Cox","year":"2016","journal-title":"Hepat. Oncol."},{"key":"10.1016\/j.drup.2026.101350_bib10","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1158\/2159-8290.CD-19-1493","article-title":"Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer","volume":"10","author":"Deblois","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2026.101350_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2020.01.016","article-title":"Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016","volume":"129","author":"Deluche","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2026.101350_bib12","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101350_bib13","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41416-024-02875-5","article-title":"The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy","volume":"131","author":"Egeland","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2026.101350_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-0716-0327-7_4","article-title":"SomaticSeq: An Ensemble and Machine Learning Method to Detect Somatic Mutations","author":"Fang","year":"2020","journal-title":"Methods Mol. Biol. 2120"},{"key":"10.1016\/j.drup.2026.101350_bib15","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/1878-0261.13656","article-title":"An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer","volume":"18","author":"Fleischer","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.drup.2026.101350_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13046-021-01938-2","article-title":"Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5\u2032-deoxy-5-fluorocytidine (5\u2032-DFCR)","volume":"40","author":"Gao","year":"2021","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101350_bib17","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"and E.G.C.E.a. clinicalguidelines@esmo.org, ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2026.101350_bib18","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1158\/1541-7786.MCR-19-0040","article-title":"The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models","volume":"17","author":"Gomez-Miragaya","year":"2019","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.drup.2026.101350_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282244","article-title":"Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7 \/ Taxol cells","volume":"18","author":"Gong","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2026.101350_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217754","article-title":"Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers","volume":"624","author":"Grimsley","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101350_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.05.023","article-title":"Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort","volume":"189","author":"Grinda","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2026.101350_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177637","article-title":"TRPM4 channels contribute to Adriamycin chemoresistance in breast cancer cells","volume":"998","author":"Guo","year":"2025","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.drup.2026.101350_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.drup.2026.101350_bib24","doi-asserted-by":"crossref","first-page":"24706","DOI":"10.1038\/srep24706","article-title":"Genome-wide profiles of methylation, microRNAs, and gene expression in chemoresistant breast cancer","volume":"6","author":"He","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2026.101350_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41523-022-00428-8","article-title":"Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance","volume":"8","author":"Hoogstraat","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.drup.2026.101350_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13148-021-01154-x","article-title":"DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application","volume":"13","author":"Hu","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.drup.2026.101350_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.drup.2026.101350_bib28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s12885-019-5939-z","article-title":"Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model","volume":"19","author":"Christowitz","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2026.101350_bib29","doi-asserted-by":"crossref","first-page":"13989","DOI":"10.1038\/s41598-024-63943-7","article-title":"In vitro evolution and whole genome analysis to study chemotherapy drug resistance in haploid human cells","volume":"14","author":"Jado","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2026.101350_bib30","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbagen.2018.02.002","article-title":"Hyperactivated m-calpain affects acquisition of doxorubicin resistance in breast cancer cells","volume":"1862","author":"Jeon","year":"2018","journal-title":"Biochim Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.drup.2026.101350_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101100","article-title":"Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration","volume":"76","author":"Ji","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2026.101350_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13148-021-01069-7","article-title":"Advances in epigenetic therapeutics with focus on solid tumors","volume":"13","author":"Jin","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.drup.2026.101350_bib33","doi-asserted-by":"crossref","first-page":"18206","DOI":"10.1038\/s41598-024-69347-x","article-title":"Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment","volume":"14","author":"Karatkevich","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2026.101350_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.149139","article-title":"Copy number variations of stepwise-selected doxorubicin-resistant MCF-7 cell lines","volume":"937","author":"Kazan","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.drup.2026.101350_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.drup.2026.101350_bib36","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"0","key":"10.1016\/j.drup.2026.101350_bib37","first-page":"8","article-title":"pheatmap: Pretty Heatmaps","volume":"1","author":"Kolde","year":"2015","journal-title":"R. Package Version"},{"key":"10.1016\/j.drup.2026.101350_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146930","article-title":"Adaptive resistance is not responsible for long-term drug resistance in a cellular model of triple negative breast cancer","volume":"850","author":"Kumar","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.drup.2026.101350_bib39","series-title":"A handbook of statistical analyses using SPSS","author":"Landau","year":"2003"},{"key":"10.1016\/j.drup.2026.101350_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003118","article-title":"Software for computing and annotating genomic ranges","volume":"9","author":"Lawrence","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.drup.2026.101350_bib41","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drup.2026.101350_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jconrel.2014.11.011","article-title":"Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells","volume":"205","author":"Li","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.drup.2026.101350_bib43","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41419-019-1871-z","article-title":"Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c\/FANCF\/REV1-mediated DNA damage response","volume":"10","author":"Lin","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2026.101350_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-025-01660-y","article-title":"Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021","volume":"18","author":"Li","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101350_bib45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2026.101350_bib46","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s10620-013-2692-z","article-title":"Increased alpha-tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma","volume":"58","author":"Lu","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.drup.2026.101350_bib47","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.1111\/jcmm.15642","article-title":"S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis","volume":"24","author":"Mahmood","year":"2020","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.drup.2026.101350_bib48","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"10.1016\/j.drup.2026.101350_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fonc.2014.00040","article-title":"In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies","volume":"4","author":"McDermott","year":"2014","journal-title":"Front Oncol."},{"key":"10.1016\/j.drup.2026.101350_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-019-0267-4","article-title":"Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise","volume":"17","author":"Morel","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101350_bib51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","article-title":"ChAMP: 450k Chip Analysis Methylation Pipeline","volume":"30","author":"Morris","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drup.2026.101350_bib52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1078-0432.298.11.1","article-title":"Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients","volume":"11","author":"Mozzetti","year":"2005","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101350_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010248","article-title":"Epigenetic Priming with Decitabine Augments the Therapeutic Effect of Cisplatin on Triple-Negative Breast Cancer Cells through Induction of Proapoptotic Factor NOXA","volume":"14","author":"Nakajima","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2026.101350_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.taap.2016.09.020","article-title":"Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters","volume":"310","author":"Nemcova-Furstova","year":"2016","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.drup.2026.101350_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2013-14-9-r105","article-title":"Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia","volume":"14","author":"Nordlund","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2026.101350_bib56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13058-024-01954-y","article-title":"Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors","volume":"27","author":"Pacaud","year":"2025","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.drup.2026.101350_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212438","article-title":"Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling","volume":"22","author":"Paramanantham","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101350_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-022-01537-9","article-title":"DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival","volume":"24","author":"Pedersen","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.drup.2026.101350_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/epi-2020-0200","article-title":"Analysis and annotation of DNA methylation in two nonhuman primate species using the Infinium Human Methylation 450K and EPIC BeadChips","volume":"13","author":"Pichon","year":"2021","journal-title":"Epigenomics"},{"key":"10.1016\/j.drup.2026.101350_bib60","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/BF02631122","article-title":"Reduction of proliferative heterogeneity of CHEF18 Chinese hamster cell line during the progression toward tumorigenicity","volume":"27A","author":"Rainaldi","year":"1991","journal-title":"Vitr. Cell Dev. Biol."},{"key":"10.1016\/j.drup.2026.101350_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274886","article-title":"Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic","volume":"17","author":"Rodallec","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2026.101350_bib62","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/bcr1370","article-title":"Comprehensive copy number profiles of breast cancer cell model genomes","volume":"8","author":"Shadeo","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.drup.2026.101350_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241515","article-title":"Genome-wide DNA methylation analysis of breast cancer MCF-7 \/ Taxol cells with MeDIP-Seq","volume":"15","author":"Shi","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2026.101350_bib64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.biopha.2013.01.004","article-title":"Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2\/M phase through p53-independent pathway in human cancer cells","volume":"67","author":"Shin","year":"2013","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.drup.2026.101350_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044963","article-title":"Gap junction enhancer increases efficacy of cisplatin to attenuate mammary tumor growth","volume":"7","author":"Shishido","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2026.101350_bib66","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1158\/1078-0432.CCR-17-0160","article-title":"The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer","volume":"23","author":"Silwal-Pandit","year":"2017","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101350_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101350_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030804","article-title":"Parallel evolution under chemotherapy pressure in 29 breast cancer cell lines results in dissimilar mechanisms of resistance","volume":"7","author":"Tegze","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2026.101350_bib69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","article-title":"A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data","volume":"29","author":"Teschendorff","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drup.2026.101350_bib70","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","article-title":"ChAMP: updated methylation analysis pipeline for Illumina BeadChips","volume":"33","author":"Tian","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drup.2026.101350_bib71","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41420-023-01450-w","article-title":"Silencing Notch4 promotes tumorigenesis and inhibits metastasis of triple-negative breast cancer via Nanog and Cdc42","volume":"9","author":"Tian","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2026.101350_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116559","article-title":"Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies","volume":"174","author":"Trnkova","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.drup.2026.101350_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2407-10-15","article-title":"Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues","volume":"10","author":"Tsuji","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2026.101350_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14050948","article-title":"DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease","volume":"14","author":"Tsyganov","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drup.2026.101350_bib75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1021\/mp3004622","article-title":"Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2\/M cycle arrest","volume":"10","author":"Vijayaraghavalu","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drup.2026.101350_bib76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2407-14-37","article-title":"Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2026.101350_bib77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12964-020-00613-x","article-title":"RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-kappaB pathway into breast Cancer progression","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.drup.2026.101350_bib78","first-page":"100","article-title":"DNMT3a mediates paclitaxel-induced abnormal expression of LINE-1 by increasing the intragenic methylation","volume":"42","author":"Wang","year":"2020","journal-title":"Yi Chuan"},{"key":"10.1016\/j.drup.2026.101350_bib79","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12032-024-02535-x","article-title":"Impaired cyclin D3 protein degradation contributes to trastuzumab resistance in HER2 positive breast cancer","volume":"41","author":"Wang","year":"2024","journal-title":"Med Oncol."},{"key":"10.1016\/j.drup.2026.101350_bib80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41420-021-00453-9","article-title":"Tubulin acetylation enhances lung cancer resistance to paclitaxel-induced cell death through Mcl-1 stabilization","volume":"7","author":"Wattanathamsan","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2026.101350_bib81","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11010-024-04989-z","article-title":"STK32C modulates doxorubicin resistance in triple-negative breast cancer cells via glycolysis regulation","volume":"480","author":"Xiao","year":"2025","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.drup.2026.101350_bib82","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-019-0081-6","article-title":"Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers","volume":"4","author":"Xu","year":"2019","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.drup.2026.101350_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102952","article-title":"RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer","volume":"68","author":"Xu","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.drup.2026.101350_bib84","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1158\/1535-7163.MCT-09-0674","article-title":"Human mutations that confer paclitaxel resistance","volume":"9","author":"Yin","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2026.101350_bib85","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1172\/JCI97924","article-title":"DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine","volume":"128","author":"Yu","year":"2018","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2026.101350_bib86","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.chembiol.2024.08.003","article-title":"A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer","volume":"31","author":"Zhang","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.drup.2026.101350_bib87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12935-018-0677-x","article-title":"RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells","volume":"18","author":"Zhou","year":"2018","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.drup.2026.101350_bib88","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","article-title":"Recent advances in targeted strategies for triple-negative breast cancer","volume":"16","author":"Zhu","year":"2023","journal-title":"J. Hematol. Oncol."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:34:19Z","timestamp":1773959659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":88,"alternative-id":["S1368764626000014"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101350","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101350"}}